ArticleMedicina (Kaunas, Lithuania)2025

A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy.

İrem Öner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.